低分子肝素治疗急性脑梗死的临床研究(2)
第1页 |
参见附件(2831KB,2页)。
总之,低分子肝素治疗急性脑梗死有效且较为安全。
参考文献
[1] Ishikawa Y, Hirayama T, Nakamura Y, et al. Incidental cerebral aneurysms in acute stroke patients:comparison of asymptomatic healthy controls.J Neurol Sci,2010,298(1-2):42-45.
[2] Kramer AH, Mikolaenko I, Deis N, et al. Intraventricular hemorrhage volume predicts poor outcomes but not delayed ischemic neurological deficits among patients with ruptured cerebral aneurysms.Neurosurgery,2010,67(4):1044-1052.
[3] Dobesh P. The importance of appropriate prophylaxis for the prevention of venous thromboembolism in at-risk medical patients.Int J Clin Pract,2010,64(11):1554-1562.
[4] Iqbal Z, Cohen M.Emerging antithrombotic agents:what does the intensivist need to know Curr Opin Crit Care,2010,16(5):419-425.
[5] Cnossen MH, van Ommen CH, Appel IM. Etiology and treatment of perinatal stroke; a role for prothrombotic coagulation factors Semin Fetal Neonatal Med,2009,14(5):311-317.
[6] Quartermain D, Li YS, Jonas S. Acute enoxaparin treatment widens the therapeutic window for tPA in a mouse model of embolic stroke.Neurol Res,2007,29(5):469-475.
共2页
您现在查看是摘要介绍页,详见PDF附件(2831KB,2页)。